Introduction: Fast growing cervix carcinomas have a pejorative outcome: the
y may occur quickly after cervical smears qualified as normal - within an i
nterval from 12 to 18 months in women less than 50 years old, and involvein
g the endocervix. This retrospective analysis is aimed at assessing 5-year
outcomes. Materials and methods: Twenty cases of fast-growing cancer of the
uterine cervix classified according to the FIGO clinical staging system as
IB (n=14), IIA (3), and IIB (3), have been reviewed and compared to a coho
rt of 160 cases not having this feature. As regard to fast-growing carcinom
a, the median age was 41 years (range 25-50), and the median follow-up 22 m
onths (8-213) as compared to 54 years (27-79) and 80 months (5-199) for the
reference cohort. The comparison of the two cohorts shows only a differenc
e of breakdown which concerns the histological pelvic lymph nodes status (P
<0.05), more often positive in fast-growing forms. The treatment policy was
equally distributed between a radio-surgical approach, cesium 137 intracav
itary irradiation followed by radical hysterectomy and lymphadenectomy, or
a definitive irradiation with pelvic external irradiation followed by cesiu
m 137 intracavitary irradiation. Results: Thirteen deaths are reported in t
he fast-growing series instead of 54 in the other series. The 5-year overal
l survival is, respectively, 34 (13-55) vs. 74% (68-82) (P<0.001), the loco
-regional-free survival 58 (33-84) vs. 85% (79-81) (P<0.001), the 5-year me
tastasis-free survival 61 (38-84) vs. 84% (78-90) (P=0.004). Conclusion: Th
ese poor results emphasize the need to intensify loco-regional therapy with
a concurrent cisplatin-based chemotherapy within the framework of a multid
isciplinary approach. (C) 2000 Elsevier Science Ireland Ltd. All rights res
erved.